Beacon Financial Advisory LLC Boosts Holdings in Colgate-Palmolive Company $CL

Beacon Financial Advisory LLC lifted its stake in Colgate-Palmolive Company (NYSE:CLFree Report) by 6.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,841 shares of the company’s stock after buying an additional 738 shares during the period. Beacon Financial Advisory LLC’s holdings in Colgate-Palmolive were worth $1,076,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Westend Capital Management LLC grew its position in Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 140 shares during the last quarter. Cornerstone Planning Group LLC grew its position in Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after purchasing an additional 287 shares during the last quarter. Saudi Central Bank purchased a new position in Colgate-Palmolive during the 1st quarter worth $29,000. Ransom Advisory Ltd purchased a new position in Colgate-Palmolive during the 1st quarter worth $33,000. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new position in Colgate-Palmolive during the 1st quarter worth $37,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Down 0.4%

CL stock opened at $78.01 on Friday. Colgate-Palmolive Company has a one year low of $77.91 and a one year high of $102.61. The stock has a market capitalization of $63.05 billion, a PE ratio of 21.91, a price-to-earnings-growth ratio of 4.06 and a beta of 0.34. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The company has a fifty day moving average of $83.29 and a 200-day moving average of $88.32.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. During the same quarter last year, the business earned $0.91 earnings per share. The business’s revenue for the quarter was up 1.0% compared to the same quarter last year. As a group, analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.43%.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on CL. UBS Group lowered their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a research report on Thursday, July 17th. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating on the stock in a research report on Thursday, September 25th. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Saturday, September 27th. Barclays reduced their target price on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a research note on Wednesday. Finally, Citigroup reduced their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a research note on Monday, August 4th. Seven analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $94.83.

Read Our Latest Stock Analysis on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.